baber/WOPTO huggingface dataset:
Patent NZ-500340-A (NZ)
Title: Multi-layer forming fabric with stitching yarn pairs integrated into papermaking surface
Inventor: WARD KEVIN J
IPC: D21F1/00
Filed: 1997-10-16
Abstract: A multi-layer papermaker's forming fabric 20 has stitching yarns integrated into the papermaking surface.  Each of a plurality of repeating units of the fabric comprises: a set of top machine direction yarns 21-30, a set of top cross-machine direction yarns 31-40 interwoven with the top machine direction yarns 21-30 (see fig 1A which is a top view of the fabric), a set of bottom machine direction yarns 41-50, a set of bottom cross-machine direction yarns 51-60 interwoven with bottom machine direction yarns 41-50 and pairs of first and second stitching yarns 61a-70a, 61b-70b (see fig 1B which is a plan view of the bottom layer of the fabric).  The stitching yarn pairs are positioned between pairs of top cross-machine direction yarns. The stitching yarns of each pair are interwoven with the top and bottom machine direction yarns such that, as a fiber support portion of the first stitching yarn is interweaving with the top machine direction yarns, a binding portion of the second stitching yarn is positioned below the top machine direction yarns, and such that as a fiber support portion of the second stitching yarn is interweaving with the top machine direction yarns, a binding portion of the first stitching yarn is positioned below the top machine direction yarns.  The first and second stitching yarns cross each other as they pass below a transitional top machine direction yarn. Also, each of the binding portions of the first and second stitching yarns passes below at least one of the bottom machine direction yarns.  In this configuration, the stitching yarns are completely integrated into the top, or papermaking, surface of the fabric, and therefore do not adversely impact the papermaking qualities of the fabric.
Patent NZ-510340-A (NZ)
Title: Expandable gastroretentive therapeutical system with prolonged stomach retention time
Inventor: KRUMME MARKUS
IPC: A61K9/00
Filed: 1999-10-23
Abstract: A gastrointensive device comprises a component, which is expandable upon contact with the gastric juice and a component containing an active compound.  A polymer shell comprising a microporous or partially microporous membrane surrounds these components.
Patent NZ-512137-A (NZ)
Title: Prostaglandin E2 (PGE2) and PGE4 analogues, which are antagonists of the EP2 receptor for treatment of female sexual dysfunction
Inventor: STJERNSCHANTZ JOHAN
IPC: A61K9/06
Filed: 2000-01-04
Abstract: The use of a prostaglandin for the manufacture of a pharmaceutical composition for the treatment of female sexual dysfunction, characterized in that said prostaglandin is a selective EP2 receptor agonist or an active prostaglandin derivative thereof, such as a salt or an ester thereof.
Patent NZ-514611-A (NZ)
Title: A system for monitoring connection pattern of data ports
Inventor: PELA PETER LAWRENCE
IPC: G06F13/12
Filed: 2000-04-05
Abstract: A system for determining and monitoring the connection pattern of data ports, which are connected by multiconductor cables without requiring special patch cables or patch panels. An adapter jacket (7) having an external contact (8) is placed over a standardized cable such as an RJ45 cable (3), which connects the data ports. An adapter board having a plurality of socket contacts is placed adjacent a plurality of data ports. An output and input module are coupled to the socket contacts. A micro-processor coupled to the output and input module scans the socket contacts to determine the connection pattern of the data ports.
Patent NZ-515510-A (NZ)
Title: Method and apparatus for extracting oocytes from ovaries
Inventor: LYONS GLENN THOMAS
IPC: A61D19/00
Filed: 2000-05-24
Abstract: A method and apparatus of extracting oocytes from ovaries. The apparatus includes an enclosure (11) for receiving a plurality of ovaries (27) and a plurality of probes (14) for repeatedly piercing the walls of the ovaries (27). The probes (14) are drivable by suitable drive means in reciprocating motion in the enclosure (11) and whereby repeated piercing of the ovary walls creates a plurality of openings in those walls through which oocytes within the ovaries (27) can be released into the enclosure (11) for collection.
Patent NZ-517071-A (NZ)
Title: Telephone number to domain name conversion
Inventor: HARRIS MARK J
IPC: H04L29/12
Filed: 2000-07-07
Abstract: An apparatus used to establish communication between two devices over a network, by using a processor that converts the telephone number portion into a multiple level domain name, which includes the converted telephone number portion. The processor optionally appends any required prefixes or suffixes to generate a complete multiple level domain name (110). Once the complete domain name is generated, communication is established with the second device.
Patent NZ-517098-A (NZ)
Title: Method for enhancing production performance in an animal
Inventor: NOSKY BRUCE J
IPC: A61K35/74
Filed: 2000-07-21
Abstract: The present invention provides a method of activating the immune system of a newborn animal and enhancing production performance of the animal comprising administering to the newborn animal an effective amount of a Mycobacterium phlei cell wall extract (MCWE), thereby activating the immune system of the animal and enhancing production performance of the animal.
Patent NZ-519310-A (NZ)
Title: Device and method for treating water with ozone generated by ultra violet (UV) light and water electrolysis
Inventor: SALAMA AMIR
IPC: C02F9/00
Filed: 2000-12-11
Abstract: A process and a device for the treatment of water, especially for removing therefrom a large variety of pollutants, especially organic, inorganic and biological pollutants through in situ generation of ozone. Ozone is economically produced (in situ) at a high concentration through the interaction of electrolytically produce oxygen and UV light having a wavelength of 189 nm. The device has a set of anode and cathode for electrolytically producing nascent oxygen that reacts with UV light at a wavelength of 189 nm to produce ozone in situ within a vessel where the polluted water is submitted to the combinative action of ozone and other oxidation reactions. The device also has a hydrocyclone or retention tank of removing cationic pollutants such as heavy metals, free radicals as well as undesirable electrolysis by-products such as nascent hydrogen through a secondary outlet. Oxidation by-products are subsequently removed from the exiting water stream by means of decantation, flocculation, coagulation or filtration.
Patent NZ-520049-A (NZ)
Title: Underfloor heating and cooling using solar and auxilary power sources
Inventor: HODGKINSON ALLAN
IPC: F24D11/00
Filed: 2002-07-08
Abstract: An underfloor climate control apparatus (1), for heating/cooling a building (6) that is constructed on a foundation of hardfill or on a block foundation, the climate control apparatus comprising a network of tubes (4) in the roof space (5) of the building for heating a fluid, a supplementary heat source (12-15) and a circulation system (2) for conducting fluid through the hardfill or foundation block of the building so that the heated fluid (7) can act to heat the hardfill/foundation block, wherein the supplementary heat source can be selected to operate in combination with the heating provided by circulation of the fluid through the network of tubes in the roof space. (61) Addition to 338087
Patent NZ-526639-A (NZ)
Title: Vibrational apparatus for drilling with rotary valve to control movement of shuttle
Inventor: PFAHLERT ROGER
Filed: 2003-06-20
Abstract: A vibration assembly is disclosed suitable for generating an output, said assembly having a frame, a head carrying, carried by, substantially locating or substantially being located by the frame, wherein the head has a spaced pair of pistons each located within a head cylinder, and wherein each headed cylinder has a valving arrangement (including a rotary valve) whereby a variable volume can be defined by the piston relative to the headed cylinder as a consequence of fluid supply into and/or fluid release from the variable volume chamber reliant on the valving arrangement, and wherein the valving arrangement of on headed cylinder is out of phase with the other such that as one chamber increases in volume as a consequence of fluid supply thereto, the other correspondingly decreases, and vice versa.
Patent NZ-527236-A (NZ)
Title: Improved burette safety valve
Inventor: BUTTERFIELD ROBERT
IPC: A61M5/168
Filed: 2002-02-01
Abstract: A system for controlling fluid flow through multiple conduits for use in a fluid administration device. The system includes a housing, a cam, and a control element used to move the cam to selectively occlude the conduits. When used with a medical burette, the cam is located between the vent and supply conduits and rotates to alternately occlude one or the other conduits or to leave both conduits patent. A cam lobe occludes the conduits by pressing the conduit against a pressure surface until occlusion is obtained. Depending on the rotational position of the cam, the continuous flow mode, the intermittent flow mode, and the priming mode are all obtained with a single control lever. The housing secures the conduits in predetermined, fixed positions both above and below the contact location of the cam to the conduit. A positive locking device is included to assist in locating the cam in the desired position. A tactile sensation is also provided to the operator by the locking device to indicate that the cam has been placed in the desired location. Clear visual indicators are included on the housing so that the flow mode in which the burette is presently operating can be seen from a distance.
Patent NZ-527414-A (NZ)
Title: Modified forms of pullulanase
Inventor: MILLER BRIAN S
IPC: C12N1/21
Filed: 1999-03-03
Abstract: A truncated Bacillus pullulanase comprising a deletion of about 100 amino acids from the amino terminus of a pullulanase obtainable from Bacillus deramificans, wherein said truncated pullulanase comprises a conserved Y region, and is capable of catalyzing the hydrolysis of an alpha-1,6-glucosidic bond. (62) Divided out of 506290
Patent NZ-527592-A (NZ)
Title: Process involving incubation of light steepwater with sulphur dioxide content of 20 to 220 ppm for at least 4 hours resulting in less than 2 percent reducing sugars remaining
Inventor: BLASZCZYK ROMAN J
IPC: A23L7/10
Filed: 2003-08-14
Abstract: A process for decreasing the reducing sugars content of light steepwater is described. Comprised in the process are steps of drawing off light steepwater having an SO2 content from about 20ppm to about 220ppm from a steeping process. Incubating the drawn off light steepwater in a complementary incubation for at least about 5 hours is then necessary. The preferential incubation temperature ranges from about 33oC to about 48oC.
Patent NZ-530326-A (NZ)
Title: Decorative materials having geometric patterns and process for preparing the same
Inventor: OLSON BARRY D
IPC: B29C48/12
Filed: 2002-08-06
Abstract: Disclosed is a decorative material having geometric patterns on a surface thereof wherein the geometric patterns are formed from at least two contrasting thermoset compositions wherein the geometric patterns are three dimensional and extend inwardly from a surface of the material, and wherein the visual appearance of the geometric patterns vary due to different cross sections of a geometric shape being exposed on the surface of the material.
Patent NZ-531113-A (NZ)
Title: Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-ylacetic acid
Inventor: DANNHARDT GERD
IPC: C07D207/20
Filed: 2002-08-21
Abstract: A method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-ylacetic acid of formula (I) is disclosed, in which 5-benzyl-3,3-dimethyl-3,4-dihydro-2H-pyrrole is reacted with omega-bromo-4-chloroacetophenone to obtain 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine, wherein an acetic acid group is introduced in the 5 position, and wherein the above said 5-benzyl-3,3-dimethyl-3,4-dihydro-2H-pyrrole is obtained by hydrogenation of 2,2-dimethyl-4-oxo-5-phenylvaleronitrile or a ketal. Methods for the production of intermediates occurring in the above method are also disclosed.
Patent NZ-531318-A (NZ)
Title: Method for treating primary insomnia
Inventor: ZISAPEL NAVA
IPC: A61P25/04
Filed: 2002-08-12
Abstract: Use of at least one compound selected from melatonin, other melatonergic agents, melatonin agonists and melatonin antagonists, in an effective amount within the range of 0.0025 to 50 mg, in the manufacture of a medicament, for treating and improving the restorative quality of sleep, in a patient suffering from primary insomnia, wherein the medicament comprises also at least one pharmaceutically acceptable diluent, preservative, antioxidant, solubilizer, emulsifier adjuvant or carrier.
Patent NZ-534664-A (NZ)
Title: GSK-3 inhibiting compounds
Inventor: BERG STEFAN
IPC: C07D405/04
Filed: 2003-03-28
Abstract: Disclosed are compounds of formula (Ia) and (Ib) wherein: P represents a 5- or 6-membered heteroaromatic ring containing one or two heteroatoms selected independently from N, O and S of which at least one atom is N; R1 is H R2 and R3 are as defined in the specification; and m and n are independently 0, 1, 2, 3 or 4. The compounds disclosed are GSK3 inhibitors having good bioavailability useful in the treatment of disorders such as Alzheimer's Disease, chronic and acute neurodegenerative diseases, bipolar disorders, schizophrenia, diabetes and hair loss amongst others.
Patent NZ-539156-A (NZ)
Title: Generic operating panel for elevator car
Inventor: FELDER HUGO
IPC: B66B3/02
Filed: 2005-03-30
Abstract: An elevator with a car operating panel (1) that comprises push buttons (6) that correspond to floors of a building, wherein the push buttons (6) act on switch contacts (9) to register elevator calls, characterised in that the push buttons (6) are reversibly mounted on the switch contacts by position lock or frictional contact or glued joint.
Patent NZ-540117-A (NZ)
Title: System and a method for presenting items to a user with a contextual presentation
Inventor: MCKEE TIMOTHY P
IPC: G06F17/00
Filed: 2004-07-30
Abstract: A computer system for presenting stored data comprises a data store and an explorer. At least a portion of the items in the data store includes one or more field entries. The explorer includes a set of parameters defining a query and one or more visual elements to be displayed in accordance with an explorer display schema. The explorer is configured to utilize the query to select items having one or more desired field entries from the data store and displays the selected items according to the explorer display schema. The query is stored as part of the explorer and defines one or more desired field entries. The explorer display schema is stored as part of the explorer and includes one or more visual elements selected for display with items having one or more desired field entries.
Patent NZ-540435-A (NZ)
Title: Rapidly disintegrating dosage form for releasing nicotine in the oral cavity or in body cavities
Inventor: LAUX WOLFGANG
IPC: A61K9/00
Filed: 2001-06-22
Abstract: Disclosed is a dosage form that rapidly disintegrates or is soluble in an aqueous environment, for rapid release of the active substance nicotine, in the oral cavity, in a body orifice or in a body cavity of an animal, including a human, wherein said dosage form comprises a matrix which contains one or more water-soluble polymers as base substances, and the active ingredient nicotine, said dosage form is characterized in that it is provided with spaces or cavities that are present in the polymeric matrix and whose contents differ from the matrix in terms of the state of aggregation, and wherein said dosage form does not contain a foam-stabilizing agent. Also disclosed are processes for production of the dosage forms.
Patent NZ-541679-A (NZ)
Title: A security system where an alarm is not activated by objects carrying signal transmission means
Inventor: FINLAYSON JOHN
IPC: G08B13/14
Filed: 2004-02-12
Abstract: A security system including a signal transmitter carried by an object, a signal receiver to receive the transmitted signals, a controller for processing received signals and controlling an alarm system in accordance with the received signals is disclosed. Presence of the objects transmitting the signals in a designated area will not activate the alarm of the alarm system, however the controller continues to allow the alarm system to be activated if the alarm system senses objects without signal transmission means in the designated area. The controller also monitors and records the number of times an object with a signal transmitter enters a designated area and monitors the object's movements within the area.
Patent NZ-542757-A (NZ)
Title: Method and apparatus for forming a document set
Inventor: HUME TAMAS
IPC: B42C1/10
Filed: 2004-04-07
Abstract: A method for forming a document set (250) is described. The document set (250) is formed from rectangular sheets of the same size and includes an envelope sheet (230) and at least one insert sheet (231, 232). The method includes the steps of printing (210) the envelope sheet (230) with envelope information, this envelope information including a unique code identifier (IDCODE 300), printing (210) each of the insert sheets (231, 232) with insert information, this insert information including a unique code identifier (IDCODE 300), and furthermore collating (240) the envelope sheet (230) and the insert sheets (231, 232) to form the document set (250). The insert sheets are then folded and the envelope sheet folded around them.
Patent NZ-548794-A (NZ)
Title: Myocardial perfusion imaging using adenosine receptor agonists
Inventor: BELARDINELLI LUIZ
IPC: A61K9/00
Filed: 2004-01-27
Abstract: Disclosed is a pharmaceutical composition comprising and A2a receptor agonist selected from CVT-3033 and CVT-3146; a liquid carrier; and at least one co-solvent selected from methylboronic acid, borate buffer and propylene glycol. Further disclosed is the use of the composition for the manufacture of a medicament for use in a myocardial imaging method.
Patent NZ-550648-A (NZ)
Title: Pharmaceutical compositions comprising an amphiphilic starch
Inventor: STANIFORTH JOHN
IPC: A61K9/20
Filed: 2005-04-14
Abstract: Disclosed is a controlled or sustained release solid pharmaceutical excipient, comprising a release controlling excipient comprising an amphiphilic starch, wherein the pharmaceutical excipient additionally comprises at least one hydrogenated vegetable oil. This controlled or sustained release solid pharmaceutical excipient may be used with a pharmaceutically active agent to produce controlled or sustained release solid pharmaceutical composition.
Patent NZ-552377-A (NZ)
Title: Combination motif immune stimulatory oligonucleotides with improved activity
Inventor: KRIEG ARTHUR M
IPC: C12Q1/68
Filed: 2002-08-19
Abstract: Disclosed is an immunostimulatory nucleic acid of 13-10 nucleotides in length comprising the formula 5'NIPyGN2P 3' wherein N1 is any sequence 1 to 6 nucleotides long, Py is a pyrimidine, G is guanine, N2 is any sequence 0 to 30 nucleotides long, and P is a GC-rich palindrome containing sequence at least 10 nucleotides long.
Patent NZ-555324-A (NZ)
Title: Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
Inventor: PFRENGLE WALDEMAR
IPC: A61K31/522
Filed: 2005-11-02
Abstract: Disclosed is a process for preparing an 8-(3-aminopiperidin-1-yl)xanthine of the general formula (I) or an enantiomer or salt thereof, wherein the substituents are as defined in the specification, comprising the following synthesis steps: a) reaction of a compound of the general formula (III) in which X is a leaving group selected from the group of halogens or sulphonic esters,with 3-(phthalimido)piperidine of formula (IV) or an enantiomer thereof, b) deprotection of the thus obtained compound of the general formula (II) and c) optional conversion to a physiologically tolerated salt. Also disclosed are the enantiomers (R)-3-(phthalimido)piperidine and (S)-3-(phthalimido)piperidine and processes for their preparation. (R)-3-(phthalimido)piperidine is a particularly preferred reactant in the process for preparing compounds of formula (I).
Patent NZ-556597-A (NZ)
Title: Membrane card and method for the production and use thereof
Inventor: DESYATOV ANDREY VIKTOROVICH
Filed: 2004-12-22
Abstract: Disclosed is a process for producing a membrane card to separate materials from fluid, comprising exposing a fluoropolymeric film to a bombardment of heavy ions, such as krypton, argon, xenon, andor bismuth, to provide the film with a track density, performing preliminary stretching of the film, and etching the sections of tracked film with an alkaline etching solution to provide the sections of film with a density of pores.
Patent NZ-560793-A (NZ)
Title: Use of TNFalpha antibodies and another drug
Inventor: FISCHKOFF STEVEN
IPC: A61K33/242
Filed: 2003-04-24
Abstract: Disclosed is the use of a human TNF-alpha antibody or antigen binding fragment thereof, in the manufacture of a medicament for the treatment of rheumatoid arthritis, wherein the medicament is formulated for administration in combination with influenza virus vaccine polyvalent.
Patent NZ-569203-A (NZ)
Title: Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing
Inventor: FABRE BERNARD
IPC: A61K8/97
Filed: 2006-12-28
Abstract: Disclosed is the use of an unsaponifiable extract of pulp from a plant, selected from the botanical family of Sapotaceae, comprising a triterpene fraction, wherein said triterpene fraction comprises erythrodiol, alpha-amyrine, beta-amyrine and lupeol, in the preparation of a cosmetic, pharmaceutical or nutraceutical product intended for preventing and/or treating skin disorders associated with skin ageing. Also disclosed is the amount of erythrodiol used being between 7 and 40% inclusive by weight of the unsaponifiable extract.
Patent NZ-576483-A (NZ)
Title: Plasma Coated Microfluidic or Nanofluidic Devices
Inventor: COULSON STEPHEN
IPC: B05D7/24
Filed: 2007-10-24
Abstract: Apparatus selected from a microfabricated device is disclosed, which comprises a microfluidic or nanofluidic device with chambers and tunnels for the containment and flow of fluid, or a component thereof wherein at least one surface thereof has a uniform non-wetting or non-absorbing coating or surface modification formed thereon by plasma processing, wherein to produce the coating or surface modification, the device or an element, component or sub-assembly thereof is exposed to a preliminary continuous plasma to pre-treat the at least one surface so a monomer or monomers can attach to the surface, followed by a plasma to allow polymerisation of the monomer(s) to proceed so the coating grows on the surface as a uniform coating having a surface energy value of less than 15 mNm-1. A method for enhancing the free-flowing properties of liquid through a microfluidic or nanofluidic device is also disclosed.
Patent NZ-578943-A (NZ)
Title: Recombinant anti-epidermal growth factor receptor antibody compositions
Inventor: PEDERSEN MIKKEL WANDAHL
IPC: A61K39/395
Filed: 2008-02-27
Abstract: Disclosed is an antibody composition comprising at least two distinct anti-human EGFR antibodies: (a) said first distinct anti-EGFR antibody is an antibody comprising the CDR1, CDR2, and CDR3 of the heavy chain SEQ ID NO: 40 and CDR1, CDR2, and CDR3 of the light chain SEQ ID NO: 72 of antibody 992; and (b) said second distinct anti-EGFR antibody is an antibody comprising the CDR1, CDR2, and CDR3 of the heavy chain SEQ ID NO: 41 and CDR1, CDR2, and CDR3 of the light chain SEQ ID NO: 73 of antibody 1024.